PLoS One

Antipurinergic Therapy Corrects the Autism-Like Features in the Poly(IC) Mouse Model.

Antipurinergic Therapy Corrects the Autism-Like Features in the Poly(IC) Mouse Model.

PLoS One. 2013; 8(3): e57380
Naviaux RK, Zolkipli Z, Wang L, Nakayama T, Naviaux JC, Le TP, Schuchbauer MA, Rogac M, Tang Q, Dugan LL, Powell SB

Autism… Continue reading

Novel Phenolic Inhibitors of Small/Intermediate-Conductance Ca(2+)-Activated K(+) Channels, KCa3.1 and KCa2.3.

Novel Phenolic Inhibitors of Small/Intermediate-Conductance Ca(2+)-Activated K(+) Channels, KCa3.1 and KCa2.3.

PLoS One. 2013; 8(3): e58614
Oliván-Viguera A, Valero MS, Murillo MD, Wulff H, García-Otín AL, Arbonés-Mainar JM, Köhler R

BACKGROUND: KCa3.1 channels are calcium/calmodulin-regulated voltage-independent K(+) channels that… Continue reading

RASopathic Skin Eruptions During Vemurafenib Therapy.

RASopathic Skin Eruptions during Vemurafenib Therapy.

PLoS One. 2013; 8(3): e58721
Rinderknecht JD, Goldinger SM, Rozati S, Kamarashev J, Kerl K, French LE, Dummer R, Belloni B

Vemurafenib is a potent inhibitor of V600 mutant BRAF with significant impact… Continue reading

Role of Ess1 in Growth, Morphogenetic Switching, and RNA Polymerase II Transcription in Candida Albicans.

Role of Ess1 in Growth, Morphogenetic Switching, and RNA Polymerase II Transcription in Candida albicans.

PLoS One. 2013; 8(3): e59094
Samaranayake D, Atencio D, Morse R, Wade JT, Chaturvedi V, Hanes SD

Candida albicans is a fungal pathogen that… Continue reading

Recombinant Measles Virus Vaccine Expressing the Nipah Virus Glycoprotein Protects Against Lethal Nipah Virus Challenge.

Recombinant Measles Virus Vaccine Expressing the Nipah Virus Glycoprotein Protects against Lethal Nipah Virus Challenge.

PLoS One. 2013; 8(3): e58414
Yoneda M, Georges-Courbot MC, Ikeda F, Ishii M, Nagata N, Jacquot F, Raoul H, Sato H, Kai C

Nipah… Continue reading

Yellow Fluorescent Protein-Based Assay to Measure GABAA Channel Activation and Allosteric Modulation in CHO-K1 Cells.

Yellow Fluorescent Protein-Based Assay to Measure GABAA Channel Activation and Allosteric Modulation in CHO-K1 Cells.

PLoS One. 2013; 8(3): e59429
Johansson T, Norris T, Peilot-Sjögren H

The ?-aminobutyric acid A (GABAA) ion channels are important drug targets for treatment… Continue reading

Randomised Controlled Trial of Brief Intervention With Biofeedback and Hypnotherapy in Patients With Refractory Irritable Bowel Syndrome.

Randomised controlled trial of brief intervention with biofeedback and hypnotherapy in patients with refractory irritable bowel syndrome.

J R Coll Physicians Edinb. 2013 Mar; 43(1): 15-23
Dobbin A, Dobbin J, Ross SC, Graham C, Ford MJ

Irritable bowel syndrome… Continue reading

The Banning of Sportsmen and Women Who Fail Drug Tests Is Unjustifiable.

The banning of sportsmen and women who fail drug tests is unjustifiable.

J R Coll Physicians Edinb. 2013 Mar; 43(1): 39-43
Shuster S, Devine JW

The use of performance enhancing drugs among elite athletes has been in the headlines… Continue reading

Health Perceptions, Self and Body Image, Physical Activity and Nutrition Among Undergraduate Students in Israel.

Health Perceptions, Self and Body Image, Physical Activity and Nutrition among Undergraduate Students in Israel.

PLoS One. 2013; 8(3): e58543
Korn L, Gonen E, Shaked Y, Golan M

This study examines health perceptions, self and body image, physical exercise… Continue reading

Amitozyn Impairs Chromosome Segregation and Induces Apoptosis via Mitotic Checkpoint Activation.

Amitozyn Impairs Chromosome Segregation and Induces Apoptosis via Mitotic Checkpoint Activation.

PLoS One. 2013; 8(3): e57461
Herman B, Gudrun A, Potopalsky AI, Chroboczek J, Tcherniuk SO

Amitozyn (Am) is a semi-synthetic drug produced by the alkylation of major celandine… Continue reading